Grant-in-Aid for Early-Career Scientists
Recent studies have been mainly focusing on type I or type III IFN responses triggered by SARS-CoV-2 infection. However, currently there is no study on the MHC class I pathway regulated by SARS-CoV-2. Our study is to investigate whether SARS-CoV-2 can suppress the host antigen-presenting pathways by scrutinizing the cellular signaling pathways that are essential for inducing MHC class I activation.
Attribution of KAKENHI